ABN Guidance Development and Endorsement

ABN Guidance Development & Endorsement

These are guidance and resources developed by external organisations, who have sought either Approval or Endorsement from the ABN.

Details on how to request Approval or Endorsement and a guide to developing guidance are included at the bottom of the page. To submit a request for the ABN's endorsement or approval of a new document, please complete the request form.

For further information, please contact the Quality Committee.

ABN Approved Guidance

Item Name	Posted By	Date Posted
The diagnosis of fibromyalgia syndrome UK (RCP) PDF (3.8 MB) [ more ] [ hide ]	Administration	10/04/2024
The diagnosis of fibromyalgia syndrome UK clinical guidelines (RCP, 2022)
Optimal clinical pathway for polio survivors PDF (1.74 MB) [ more ] [ hide ]	Administration	10/04/2024
Optimal clinical pathway for polio survivors (including the late effects of polio and post-polio syndrome) (British Polio Fellowship, 2024)
JCV testing with natalizumab biosimilar Link [ more ] [ hide ]	Administration	29/05/2025
Approach to JCV testing with natalizumab biosimilar: a UK consensus statement
EAN NEUROGED Guidelines PDF (2.53 MB) [ more ] [ hide ]	Administration	02/09/2025
European Academy of Neurology (EAN)/European Federation of Autonomic Societies (EFAS)/International Neuro-Urology Society (INUS) Guidelines for Practising Neurologists on the Assessment and Treatment of Neurogenic Urinary and Sexual Symptoms (NEUROGED Guidelines) Urogenital symptoms are commonly reported following neurological disease and a multidisciplinary inter-society evidence-based guideline has recently been published with ABN approval. The 38 recommendations in the guideline offer a framework for practising neurologists on the assessment and treatment of urinary and sexual symptoms reported by their patients. The document includes two algorithms that illustrate the recommendations, a check list of symptoms to enquire about in a neurology clinic, and red flag symptoms that warrant shared care with allied specialists.

ABN Endorsed Guidance

Item Name	Posted By	Date Posted
Using disease- modifying treatments in MS Link [ more ] [ hide ]	Administration	07/05/2025
This updated guidance provides a consensus- based approach to using DMTs. We provide recommendations for eligibility, starting, monitoring, switching and stopping of DMTs; pregnancy; equitable access to DMT; autologous haemopoietic stem- cell transplantation; and use of generics. We highlight best practice where it exists and discuss future priorities.

ABN's Guidance Development, Endorsement & Approval

[ More Info Hide Info ]

ABN's Guidance Development, Endorsement & Approval process

Item Name	Posted By	Date Posted
ABN Endorsement Policy PDF (89.76 KB) [ more ] [ hide ]	Administration	04/04/2024
Full details of the endorsement and approval process
ABN's Guidance Development Information PDF (116.62 KB)	Administration	16/04/2024
ABN Guidance Development Process PDF (202.48 KB)	Administration	02/09/2025

	Edit This Favorite
Name:
Category:
Share:	Yes No, Keep Private

Edit This Favorite

ABN Approved Guidance

ABN Endorsed Guidance

ABN's Guidance Development, Endorsement & Approval